ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
17.87
-0.05 (-0.28%)
At close: Jul 25, 2025, 4:00 PM
18.22
+0.35 (1.96%)
After-hours: Jul 25, 2025, 7:04 PM EDT

ARS Pharmaceuticals Revenue

ARS Pharmaceuticals had revenue of $7.97M in the quarter ending March 31, 2025. This brings the company's revenue in the last twelve months to $97.12M, up 971,120.00% year-over-year. In the year 2024, ARS Pharmaceuticals had annual revenue of $89.15M with 297,063.33% growth.

Revenue (ttm)
$97.12M
Revenue Growth
+971,120.00%
P/S Ratio
17.96
Revenue / Employee
$607,013
Employees
160
Market Cap
1.76B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202489.15M89.12M297,063.33%
Dec 31, 202330.00K-1.29M-97.72%
Dec 31, 20221.32M-4.19M-76.10%
Dec 31, 20215.51M-12.33M-69.13%
Dec 31, 202017.84M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group410.06B
Johnson & Johnson90.63B
Merck & Co.63.92B
AbbVie57.37B
Novartis AG55.19B
AstraZeneca54.98B
Eli Lilly and Company49.00B
Novo Nordisk43.92B
Revenue Rankings